Sedation for Post-Cardiac Arrest Obese Patients
Start with fentanyl as first-line (25-100 μg bolus, then 25-300 μg/h infusion), add propofol (0.5-1 mg/kg bolus, then 20-60 μg/kg/min) if sedation remains inadequate, and dose both medications using lean body weight (LBW) or adjusted body weight (ABW)—never total body weight—to avoid hemodynamic collapse and delayed awakening. 1, 2
Medication Selection Algorithm
First-Line: Opioid Analgesic
- Fentanyl is the primary agent for post-cardiac arrest sedation 1
- Provides analgesia, sedation, and anti-shivering effects
- Bolus: 25-100 μg (0.5-2 μg/kg based on LBW)
- Infusion: 25-300 μg/h (0.5-5 μg/kg/h based on LBW)
- Duration of action: 1-4 hours
- Alternative: Remifentanil (0.5-15 μg/kg/h) has shorter duration and no accumulation in organ dysfunction, making it preferable in obese patients 3
Second-Line: Add Sedative if Inadequate
- Propofol when fentanyl alone fails to achieve adequate sedation 1
Avoid or Use Sparingly
- Midazolam: Reserve only for severe hemodynamic instability where propofol is contraindicated 1
- Highly deliriogenic, causes delayed awakening, accumulates in renal dysfunction 1
- If used: 2-5 mg bolus, 1-8 mg/h infusion
- Continuous benzodiazepine infusions: Avoid except for active seizure control 1
Later Recovery Phase
- Dexmedetomidine: Transition during rewarming/weaning phase 1
- Does not suppress respiratory drive
- Lower delirium risk than benzodiazepines
- Ineffective for deep sedation or severe ventilator dyssynchrony
Obesity-Specific Dosing Considerations
Weight Scalars to Use
Never dose to total body weight (TBW) in obese patients—this causes overdosing, hemodynamic instability, and delayed awakening 2, 4
Use these formulas 2:
Lean Body Weight (LBW) - preferred for most agents:
- Men: LBW = [9270 × TBW] ÷ [6680 + (216 × BMI)]
- Women: LBW = [9270 × TBW] ÷ [8780 + (244 × BMI)]
- LBW rarely exceeds 100 kg (men) or 70 kg (women) regardless of TBW
Adjusted Body Weight (ABW) - alternative:
- ABW = IBW + 0.4 × (TBW - IBW)
- Where IBW = height (cm) - 100 (men) or height (cm) - 105 (women)
Why This Matters
- Excess adipose tissue has low blood flow; lipophilic drugs distribute differently 2
- TBW-based propofol dosing increases hypotension and bradycardia without improving sedation adequacy 4
- Obese patients have altered clearance and volume of distribution requiring individualized weight-based calculations 4
Sedation Depth Strategy by Phase
Induction Phase (0-2 hours post-ROSC)
- Deep sedation required 1
- Fentanyl bolus + infusion at moderate-to-high dose
- Add propofol infusion
- Consider neuromuscular blockade (NMB) if shivering persists despite sedation
- Must provide amnesia if using NMB—propofol or midazolam required 1
Maintenance Phase (2-24 hours)
- Moderate sedation 1
- Continue fentanyl and propofol at minimum doses that suppress shivering
- Titrate down sedatives as tolerated
- Avoid excessive sedation—increases delayed awakening risk 1
Rewarming Phase (24-48 hours)
- Light sedation 1
- Wean to lowest tolerated doses
- Discontinue NMB completely
- Begin neurological assessments
Post-TTM Normothermia (>48 hours)
- Minimize or avoid sedation 1
- Discontinue all sedatives if possible
- Assess neurological status
- Critical: Sedative accumulation causes delayed awakening—wait ≥72 hours after discontinuation before neuroprognostication 1
Evidence-Based Outcomes
Recent high-quality data from the TTM2 trial post-hoc analysis 5 showed:
- Moderate propofol doses (100.7-153.6 mg/kg cumulative over 72h) associated with better functional outcomes (OR 1.62) and survival (OR 1.84)
- Fentanyl use associated with good outcomes (OR 1.69) and survival (OR 1.80)
- Remifentanil use associated with good outcomes (OR 1.50) and survival (OR 1.56)
- Highest propofol doses (>153.7 mg/kg) associated with late awakening (OR 3.19)
- As-needed NMB strategy superior to continuous NMB or NMB avoidance 6
Critical Pitfalls in Obese Patients
Hemodynamic Instability
- All sedatives ablate sympathetic tone causing hypotension, bradycardia, low cardiac output 1
- Obese post-arrest patients often have shock and vasopressor dependence—sedation worsens this 1
- Propofol has highest hypotension risk; consider midazolam if severe instability 1
Delayed Awakening
- Hypothermia + organ injury + obesity = prolonged drug clearance 1
- Sedative accumulation leads to inaccurate neuroprognostication and premature withdrawal of care 1
- Wait minimum 72 hours after rewarming AND sedation discontinuation before prognostication 1
Respiratory Complications
- Obese patients have higher hypoxemia and airway intervention rates with sedation 4
- Opioids suppress respiratory drive—problematic if spontaneous breathing required 3
- Consider dexmedetomidine during weaning (no respiratory depression) 3
Drug-Specific Toxicities
- Propofol infusion syndrome: Limit to <6 days continuous use 3
- Fentanyl: Risk of tachyphylaxis, accumulation, withdrawal with prolonged infusion 1
- Midazolam: Active metabolite accumulates in renal dysfunction (common post-arrest) 1
Practical Implementation
- Calculate LBW immediately using formulas above
- Start fentanyl (50-100 μg bolus based on LBW, then 50-150 μg/h)
- Add propofol if inadequate (0.5 mg/kg LBW bolus, then 30-50 μg/kg/min LBW)
- Titrate to effect: Richmond Agitation-Sedation Scale ≤-4 during first 40 hours 5
- Monitor closely: Blood pressure, heart rate, oxygen saturation
- Wean aggressively after 24 hours to minimize accumulation
- Switch to dexmedetomidine during recovery/weaning phase
- Delay neuroprognostication ≥72 hours after sedation stopped
This approach balances adequate sedation for shivering control and patient comfort against the substantial risks of hemodynamic compromise and delayed awakening that disproportionately affect obese post-cardiac arrest patients.